TRT and HIV: How Low Testosterone Is Tested, Treated, and Monitored When You're Living With HIV
Yes — TRT and HIV treatment can be used together in some men with confirmed low testosterone. TRT means testosterone replacement therapy. Diagnosis needs symptoms or signs plus consistently low results on repeat early-morning fasting tests. HIV can raise the blood protein SHBG, so free testosterone may matter. Your medicines, blood count, blood pressure, and fertility plans need a check.
This page is educational information, not medical advice. Decisions about testing and treatment belong with a clinician who knows your full health history.
This guide is for you if: you're an adult man living with HIV and you have symptoms of low testosterone, a confusing lab result, or a testosterone prescription you want to double-check.
This guide is not the right fit if: you're looking for gender-affirming hormone care, care for a teen, or advice on steroids for muscle or sport. Those use different medical standards. Gender-affirming care deserves its own guide and your gender-affirming care team.
That first point catches a lot of men. In one large U.S. study, about 1 in 3 men with HIV who were not taking TRT and met the study's biochemical definition of low testosterone had a "normal" total-testosterone result. A total-only test would have missed them. Below, we'll show you which tests address that gap, which HIV medicines may interact with prescribed testosterone (we checked them by name), and what to ask before choosing care. Study details
What changes the answer for you:
- Your HIV regimen. Regimens boosted with cobicistat or ritonavir may raise testosterone exposure. Efavirenz may lower it. Biktarvy is not expected to have a clinically significant interaction with prescribed testosterone.
- Unplanned weight or muscle loss. That needs a full workup with your HIV clinician first. It's not a reason to start TRT online.
- Plans to have biological children. Standard TRT can lower or stop sperm production. Talk to a reproductive urologist before you start.
- Long-acting injectable HIV treatment (Cabenuva). It has a specific caution with testosterone. Ask for a check before you start.
- Timing. Testosterone is a controlled drug. The temporary federal rule that allows qualifying clinicians to prescribe it by video without a prior in-person evaluation runs through December 31, 2026. Federal and state requirements still apply. Federal rule
The testing and care points above follow HIVMA/IDSA guidance and the Endocrine Society guideline; the medicine-specific checks are linked in the interaction table below.
TRT Provider Guide is the independent decision resource for testosterone replacement therapy — helping U.S. adults understand how low testosterone is evaluated, compare online and local care models and providers, and choose the next step that fits their health needs, fertility plans, budget, state, and care preferences, with every material claim verified and dated.
Can HIV cause low testosterone?
Low testosterone can occur in men with HIV even when HIV is well controlled. Estimates vary widely with the men studied and whether total or free testosterone is used. It can also show up at younger ages than you'd expect. Research review
Before effective HIV treatment arrived in the mid-1990s, some studies found low testosterone in about half of men with symptomatic HIV. Treatment changed that a lot. But it didn't make the problem go away. Historical research
Here's what the research shows in these studies:
Sources: Monroe et al., 2014; Lachâtre et al., 2017; De Vincentis and Rochira, 2023; Wunder et al., 2007. These studies used different definitions. A low result in a prevalence study is not the same as a confirmed clinical diagnosis.
What does "HIV-related hypogonadism" mean?
Hypogonadism means your body doesn't make enough testosterone, or the brain signals that control testosterone are off. (Our guide to what hypogonadism means covers the basics.)
In men with HIV, the problem is often in the brain signal. Your pituitary gland sends a hormone called LH (luteinizing hormone) that tells the testicles to make testosterone. In many men with HIV, LH is normal or low when it should be high. Doctors call that secondary hypogonadism.
"HIV-related" doesn't mean HIV caused your number. It means HIV is part of the picture your clinician needs to sort through.
What else can lower testosterone in men with HIV?
Possible contributors include extra body fat. Getting older. Long-term inflammation. Hepatitis C. Weight loss from illness. Opioids. Poor sleep. Causes and assessment
Which symptoms are worth bringing up?
The HIV primary care guidance from the HIV Medicine Association and the Infectious Diseases Society of America (HIVMA/IDSA, 2024) says testosterone testing makes sense when a man has:
- Lower sex drive
- Erection problems
- Thinning bones or a fracture from a minor fall
- Hot flashes or sweats
Fatigue, low mood, and muscle loss can also come from low testosterone. But they can also come from HIV itself, depression, poor sleep, or another medicine.
Our take: your symptoms are real. They're just not proof of low testosterone. That's why the test matters so much — and why the next section matters when total and free testosterone tell different stories.
Why can a "normal" testosterone test miss low T in men with HIV?
Most testosterone in your blood is attached to proteins, including SHBG (sex hormone-binding globulin) and albumin. HIV can raise SHBG, so total testosterone can read normal while free testosterone — the unbound portion — is low. In the MACS study, 11 of 34 men with HIV who were not taking TRT and met its biochemical definition of low testosterone had a normal total-testosterone result. Study
Think of SHBG like a fleet of taxis that holds its riders tightly. Testosterone also rides with albumin, which holds it more loosely. Free testosterone is the testosterone walking around on its own. Some albumin-bound testosterone is also available to tissues.
A total testosterone test counts everyone — riders and walkers. If HIV raises SHBG, the total can look fine while the free fraction is low. How the proteins affect testing
That's not a theory. In MACS, about a third of the men with HIV who were not taking TRT and met the study's biochemical definition had normal total testosterone but low calculated free testosterone. Among the 12 men without HIV who were not taking TRT and met that definition, none had that pattern. The men with the normal-total, low-free pattern had much higher SHBG and were more likely to have hepatitis C. MACS results
Do the experts agree on which test to use?
Not completely. Here's where the main sources stand — and what we think you should ask for.
Our editorial read: ask how both total and free testosterone will be assessed. Free testosterone can be measured by equilibrium dialysis or calculated with a validated formula using total testosterone, SHBG, and albumin. Your clinician should choose a reliable method. It can catch the pattern that total-only testing misses. Testing guidance
Want more detail on lab methods? See our deep dive on testosterone test accuracy.
What tests should men with HIV ask for before TRT?
Ask about two early-morning fasting testosterone tests on different days, with free testosterone assessed when SHBG may be altered. Your clinician can choose a reliable measured or calculated method. Before treatment, discuss a blood count, a prostate-risk review, and every medicine you take. Diagnostic guidance
Here's the list to discuss, and why each test earns its spot. LH and FSH help find the cause once low testosterone is confirmed.
A few terms, quickly. FSH (follicle-stimulating hormone) is LH's partner and also drives sperm production. Hematocrit is the share of your blood made of red blood cells. PSA is a protein made by the prostate.
Three testing mistakes to avoid
- Testing while you're sick. Acute illness can drag testosterone down for a while. Ask your clinician when to test after recovery.
- Testing in the afternoon. For people who sleep at night, testosterone runs highest in the morning, so an afternoon test can read lower. If you work nights, ask your clinician how to time the sample around your sleep. Joint society position statement
- Trusting one number. One low result isn't a diagnosis. Neither is a number below a cutoff like 300 ng/dL by itself. Symptoms, repeat tests, and the cause all count. (More on this in how low testosterone is diagnosed.)
Already on TRT and missing your "before" labs?
Results taken while you're on testosterone can't tell you what your levels were before treatment. Bring any old lab reports you can find. Don't stop treatment just to get a new baseline. Talk to your prescriber first.
At-home kits vs a lab draw
At-home finger-prick kits are convenient. But a kit may not measure SHBG, free testosterone, or a blood count. Check a kit's test list before you pay for it. For men with HIV, those missing pieces can change the next step. The provider comparison below shows the published differences.
Next step: Jump to the printable appointment checklist below. It puts the key questions and records to bring into a checklist you can hand to your clinician.
Affiliate disclosure: TRT Provider Guide may earn a commission when you use partner links on the site, including links reached through its tool. Payment does not determine the medical guidance here. See our affiliate disclosure.
The right TRT provider is not the same for every person — it depends on whether low testosterone has been properly evaluated, your symptoms and health history, your fertility plans, your state, your insurance or cash-pay preference, your treatment-format preference, your budget, and whether online or in-person care is the better starting point. Some situations belong with primary care, urology, endocrinology, reproductive urology, or urgent or emergency care when the symptoms warrant it. Because a general answer cannot resolve those for you, use the checklist with your HIV care team to map your situation to the right care route and the questions to ask before you pay. If online care is appropriate, TRT Provider Guide's Find My TRT Path tool can help you explore general online TRT programs.
Not sure your last test told the whole story? A total-only test can leave this question unanswered. Bring the checklist to your HIV team first. If you're ready to explore online options, use Find My TRT Path →. Free. Five questions. It's educational, doesn't diagnose, doesn't decide treatment eligibility, and doesn't check drug interactions — your HIV care team does that. Read our privacy policy.
Do HIV medications interact with testosterone?
Some HIV medicines may interact with prescribed testosterone. Regimens boosted with cobicistat or ritonavir may raise testosterone exposure, while efavirenz may lower it; Biktarvy is not expected to have a clinically significant interaction. Long-acting injectable cabotegravir/rilpivirine carries a specific caution about HIV-drug exposure.
Your pharmacist or prescriber should check your exact regimen — never change HIV medicines on your own.
Several expected interactions involve the liver enzyme CYP3A4. Your body uses it to break down testosterone.
- "Boosters" (cobicistat and ritonavir) slow that enzyme. Testosterone may build up higher than expected.
- Efavirenz speeds that enzyme up. Testosterone may clear faster and run lower.
- Many integrase-based regimens don't touch that enzyme much, so no change is expected.
None of this means you can't have TRT. It means your clinician may need to watch your levels and side effects more closely.
What we checked, by regimen
We checked six individual entries in the University of Liverpool HIV Drug Interactions checker on October 30, 2026. We checked the additional combinations and components in Liverpool's summary charts revised June 2026. The table separates those two kinds of checks.
Sources: the six linked University of Liverpool entries, June 2026 summary charts, and Liverpool's androgen-interaction guidance for the predicted direction of metabolism changes. These are interaction predictions, not comparative trials of TRT in men with HIV.
Read this before you use the table:
- The six individual Liverpool entries rate the evidence "very low" and report no formal coadministration studies. The Cabenuva entry also cites one case report. "No interaction expected" is a prediction based on how the drugs are processed. It's not proof of zero risk.
- A reassuring result for one pill doesn't clear every regimen with a similar name. Your other prescriptions and supplements count too.
- This table is about interactions between HIV medicines and prescribed testosterone. It doesn't tell you whether an HIV medicine caused low testosterone.
Why does Cabenuva get its own warning?
Liverpool flags a published 2024 case report involving a man using anabolic steroids and testosterone for bodybuilding while receiving long-acting cabotegravir/rilpivirine. Low HIV-drug concentrations, virologic failure, and resistance were reported. The authors proposed a possible contribution from steroid use and muscle-related changes; other risk factors were present.
That was one person, and Liverpool's case summary does not quantify his doses. It doesn't prove that prescribed TRT causes HIV treatment to fail. But Liverpool advises caution and suggests extra monitoring. If you get Cabenuva, ask your HIV team whether to check your drug levels or viral load more often. Liverpool's case summary and advice
Should I switch HIV medicines so I can take TRT?
No — not based on this page. Only your HIV prescriber should change your HIV treatment. Testosterone doesn't treat HIV and never replaces it. Keep taking your regimen as prescribed and raise any concerns with your HIV team.
Is TRT safe if you have HIV?
For men with symptoms and confirmed low testosterone, TRT may be appropriate after an individual benefit–risk review, with monitoring. The risks to watch are a rising red-blood-cell count, higher blood pressure, heart risk, prostate health, and fertility. A small, 12-week trial in men with HIV found no statistically significant change in CD4 counts or viral load. Trial
Here's the short version of what to watch and why HIV matters.
Sources: HIV polycythemia study, FDA blood-pressure action, HIVMA/IDSA guidance, and Endocrine Society guidance.
Will testosterone lower my CD4 count or raise my viral load?
A 12-week randomized trial in 41 men with HIV and low testosterone found no statistically significant change in CD4 counts, CD8 counts, or viral load. Red blood cell counts did go up. 1998 trial
That's reassuring, but keep it in perspective. The trial was small and older. Your HIV team should keep tracking your HIV labs the way they normally do.
What about my heart?
You'll see reassuring trial evidence and a gap in HIV-specific long-term evidence. Both matter.
- The worry: HIV raises heart risk even when the virus is suppressed. HIVMA/IDSA urges caution with testosterone because long-term benefit and harm in people with HIV remain uncertain. HIV-specific guidance
- The reassurance: TRAVERSE randomized 5,246 symptomatic men aged 45–80 with confirmed low testosterone and existing or high heart risk. Testosterone gel met the trial's standard for not being worse than placebo for the combined outcome of cardiovascular death, nonfatal heart attack, or nonfatal stroke. Atrial fibrillation (an irregular heart rhythm), acute kidney injury, and pulmonary embolism (a blood clot in the lungs) occurred more often with testosterone. This was not an HIV-specific trial. TRAVERSE
Based on TRAVERSE, in February 2025 the FDA announced removal of increased cardiovascular-risk language from testosterone boxed warnings. It also required new or updated blood-pressure warnings based on separate blood-pressure studies. FDA announcement
What that means for you: get your heart risk managed alongside TRT. That means blood pressure, cholesterol, and smoking. It's especially important with HIV.
How do the newest label changes affect me?
On June 18, 2026, HHS announced that the FDA had asked drugmakers to update testosterone labels. The requested changes would narrow the prostate-cancer contraindication to metastatic prostate cancer, revise the enlarged-prostate warning, and remove a limitation saying safety and effectiveness for age-related low testosterone had not been established. These were requests. Your specific product's current label is what counts, so ask your prescriber. The requested changes still call for prostate-risk assessment and monitoring. HHS announcement
Who should hold off on starting TRT for now?
Talk this through with your clinician first if any of these apply; this is not a complete list:
- You have untreated severe sleep apnea
- Your hematocrit is already high
- You've had a heart attack or stroke within the past six months
- You have uncontrolled heart failure
- You have prostate or breast cancer, or a prostate finding that hasn't been checked out
- You're trying to conceive
- You have a condition that increases your risk of blood clots (thrombophilia), or severe urinary symptoms
These are reasons for a clinician to review whether treatment is appropriate, using the current product label and your history. Endocrine Society guidance
Our TRT safety guide covers each of these in more depth.
Get emergency care now for chest pain or pressure that doesn't go away, sudden severe trouble breathing, or sudden weakness on one side or trouble speaking. Don't wait for a testosterone appointment.
What about HIV wasting or weight loss you didn't plan?
Unplanned weight or muscle loss with HIV needs a full medical workup first. It isn't a reason to start TRT online. The Endocrine Society suggests clinicians consider short-term testosterone for men with HIV who have both low testosterone and weight loss, once other causes are ruled out. Guideline
That recommendation comes from older trials in a specific group. A 16-week trial published in 2000 randomized 61 men with low testosterone and weight loss to testosterone or placebo, with or without resistance exercise. Testosterone alone improved weight, lean mass, and strength; results varied across the four groups. Trial That doesn't promise the same result for men without weight loss, and it says nothing about long-term safety.
Weight loss is not required for treatment of confirmed symptomatic hypogonadism. In men with that diagnosis, TRT can improve sexual desire and activity; improvement in erections is usually modest. Fatigue and mood may not improve. Agree with your clinician on which symptoms treatment is expected to help and when to reassess them. Evidence on benefits
Before anyone reaches for testosterone, your HIV clinician will look for other causes. These include infections, problems absorbing food, depression, trouble getting enough to eat, and whether your virus is controlled.
Two more facts worth knowing:
- Serostim (somatropin) is FDA-approved for adults with HIV wasting or cachexia who are taking HIV treatment. It is growth hormone, not TRT. That's a separate decision for your HIV clinician. Prescribing information
- Oxandrolone used to be prescribed for wasting. The FDA withdrew approval of the remaining approved oxandrolone tablets on June 28, 2023. Its October 2026 correction confirms the withdrawal and safety/effectiveness determination. HIV clinicians at UCSF also advise against other anabolic steroids for safety reasons. FDA withdrawal · 2026 correction · UCSF guidance
If you're losing weight without trying, contact your HIV clinician promptly. This needs a medical workup before an online TRT decision.
What happens to fertility on TRT?
Standard testosterone therapy can lower or stop sperm production, so it shouldn't be used if you're trying to conceive. If biological children are in your plans, see a reproductive urologist before starting. No option can promise to protect fertility. AUA/ASRM fertility guidance
Here's why. When testosterone comes from outside your body, your brain notices and cuts back on LH and FSH. Those are the signals your testicles need to make sperm. The AUA/ASRM male-infertility guideline says testosterone alone should not be prescribed to men interested in current or future fertility. Sperm production may recover after testosterone is withdrawn under medical care, but the timing and extent of recovery are not guaranteed. Fertility guidance
Which fertility-related medicines are not TRT?
Some clinicians use other medicines, like hCG or clomiphene, to try to keep your own production going. These are not testosterone replacement therapy. They have their own risks, and they don't guarantee anything.
- Clomiphene: use in men is off-label. Its FDA-approved indication is for certain ovulation problems in women. Label
- hCG: some products, such as Pregnyl, are FDA-approved for selected men with hypogonadotropic hypogonadism — low testosterone caused by weak hormone signals from the brain. That does not make every fertility regimen an approved use or guarantee sperm production. Label
- Enclomiphene: this drug is not FDA-approved. A compounded preparation does not change that status. Current federal drug information
Planning a family with HIV is its own conversation, and your HIV clinician is the right person to start it with. Our guide on TRT and fertility goes deeper.
Where should men with HIV get TRT?
For most men, start with your HIV clinician or an endocrinologist. Your HIV team knows your regimen and can help coordinate testing; confirm insurance coverage with the office and your plan. If you go online, a lab panel is only the first check — the program also needs to accept your case, review your medicines, and agree on follow-up with your HIV team.
Your options at a glance
Why your HIV clinic is often the strongest first choice
Your HIV team already runs your blood counts and knows your regimen. They can order or arrange hormone testing; ask your insurer about coverage. Ask whether the exact testosterone product needs prior authorization. If you get HIV medicines through Ryan White or ADAP, each state sets its own drug list, so ask your case manager what's covered. ADAP rules
There's one honest catch. HIV clinics haven't always tested well. In a single-center chart review published in 2017, 88% of 50 men managed by HIV medicine started TRT without a second confirmatory low testosterone result — the highest of the four specialties studied. That is a historical finding, not a current rate for HIV clinics. That's why you walk in with the checklist. Study
What does online TRT look like for men with HIV?
We compared the three online programs below against the testing and follow-up questions raised by HIV guidance. Here's what each one publishes. This is a comparison of public documents, not evidence that any program is equipped to manage your HIV-related care. See How We Review TRT Providers.
Published lab coverage: what each route lists
Provider-stated facts from Hone's Premium details and lab schedule, Male Excel's test page and terms, and Taurus's test page, checked October 30, 2026. "Not listed" describes the public page; it does not prove a clinician never orders that test. No panel alone confirms a diagnosis or a program's suitability for someone with HIV.
FDA-approved testosterone, compounded testosterone, and other hormones
Compounded drugs are not FDA-approved. FDA does not review them for safety, effectiveness, or quality before they are marketed. A compounded testosterone preparation is not the same approval category as an FDA-approved testosterone product. Thyroid medicine is a separate treatment, not TRT. FDA explanation · Hone product disclosure · Male Excel pricing · Taurus homepage and offer
First-year cost scenarios and charges still to confirm
Our math assumes 12 months at the stated recurring price; it is not a guarantee of a 12-month rate. Your product, prescription, refill schedule, and insurance can change the price. Hone's $1,950 is $65 + $25 + ($155 × 12); its $2,286 example adds $336. Male Excel's $2,727 is $99 + $1,188 + $1,440. Taurus's historical offer calculations are $49 + ($149 × 12) and $49 + ($199 × 12).
Price sources: Hone Premium details and TRT page; Male Excel current pricing; Taurus's company-issued May 2026 release, current offer, and terms, section 28. Checked October 30, 2026.
Hone Health: what its published panel includes
Hone is the online program in this set whose published Premium panel lists calculated free testosterone, SHBG, LH, hematocrit, hemoglobin, and PSA. Prolactin is listed with the separate confirmatory test, not as part of that initial draw. These are useful published details; they do not establish that Hone will accept your case or coordinate with your HIV team.
What it costs: a $65 lab test to start, plus a listed $25 confirmatory test. Premium membership is $155 a month, which Hone says covers follow-up lab testing, physician consults, and shipping. Medication costs extra. The TRT page advertises testosterone from $28 a month, while Premium help lists testosterone cypionate from $28 per vial. Compounded cream and dissolvable troches start at $60 a month. Hone says there's no commitment and you can cancel anytime. It doesn't take insurance. Premium details · TRT page · Insurance policy
What to know first:
- Hone's membership costs more than Male Excel's. The published starting prices do not establish which will cost less for your actual prescription and monitoring needs.
- Hone's testosterone product page discloses compounding. Ask for the exact medication, manufacturer or compounding pharmacy, and dispensing pharmacy before you pay. A named pharmacy should be checked with the relevant state pharmacy board. Product disclosure
- Hone's reviewed clinical policy does not establish an HIV-specific acceptance or coordination policy. Tell the physician about your HIV and every medicine you take. Clinical policy
- Hone lists follow-up labs at months 3, 6, 9, and 12 in the first year. That schedule does not replace an individual plan for medicine interactions, symptoms, and blood counts. Lab schedule
- Premium availability varies by state. Its current help pages say an at-lab draw is required, while the marketing page advertises in-home draws where available. Confirm the collection method for your state before ordering. State and program availability
- Cancel the membership and the prescription service separately. Hone's policy says there are no partial-month membership refunds and no refunds for processed or shipped prescriptions. Cancellation policy
If you want free testosterone, SHBG, and your blood count checked in one draw, that's what Hone's initial panel lists. Before ordering, ask whether its clinician can review your HIV regimen and share the follow-up plan with your HIV team. Ordering the lab test doesn't mean you'll get a prescription. A physician reviews your results first.
Male Excel: what its intake test lists
Male Excel does not list free testosterone or SHBG in its at-home kit. If you still need a diagnosis, start with your HIV clinician or an endocrinologist. The $99 test and consult do not establish that the program will accept outside diagnostic results or manage HIV-related care. Male Excel advertises a dedicated provider and check-ins every 60 days; confirm how those would work for your case. Test details · Provider's service description
What it costs: $99 to start, covering the at-home test and a provider consult. Then a $99 monthly membership. Male Excel lists injections with thyroid medicine from $120 a month and cream with thyroid medicine from $132 a month, each sent as a 60-day supply, billed every other month, plus shipping. It lists no contract, says you can cancel anytime, and accepts HSA/FSA payments subject to your plan's rules. It doesn't take insurance. Current pricing · Terms
What to know first:
- Male Excel's hormone medicines are compounded. The company states they are not FDA-approved. Thyroid medicine needs its own clinical reason; it is not part of testosterone replacement itself. Company disclosure
- Its at-home test checks total testosterone, estradiol, DHEA-S, free T3, and PSA. It doesn't list a blood count. Agree on who orders and reviews hematocrit and any other needed tests; do not assume the kit covers them. Test list
- Male Excel says it treats based on symptoms, not just lab numbers. Symptoms alone do not confirm low testosterone; the diagnosis still needs appropriate repeat results and a cause assessment. Diagnostic standard
- Male Excel notes that DEA and state laws may require an in-person exam. Its FAQ lists states it does not serve, so confirm current availability where you will receive care. Service FAQ
- The company describes refill notices before its 60-day shipments and a 48-hour response window. Its general terms make fees nonrefundable unless a separate written policy says otherwise; dispensed prescriptions are generally final. Confirm the cancellation deadline and any exception before paying. FAQ · Terms · Refund policy
Already have confirmed low testosterone from your HIV clinic's labs, and want check-ins every 60 days? Ask whether Male Excel will accept those records and who will review your blood count and HIV-drug interactions before moving care. Share your HIV clinic's lab reports and your full medicine list at your consult.
Taurus Meds
Taurus advertises a $49 test-and-consult offer, while its homepage promotes a free first test. Its test page describes eight biomarkers but does not name them. For a man with HIV, that's the whole question. We can't assess its fit for HIV-aware testing until those details and its care process are clear, so we're not recommending it here. Test page · Homepage
The published pages do not establish a complete TRT quote, and the medication disclosures need clarification. One offer says $149 a month with no membership fees, while the general terms list a recurring $17.99 fee per billing period and allow different terms at purchase. Ask whether the offer waives that fee and what billing period applies. The homepage's FDA-approved claim sits alongside an offer page that describes compounded hormones. Get the exact panel, prescription, full 12-month charges, commitment, and cancellation terms in writing before paying. Its refund policy asks for cancellation at least 72 hours before billing; shipped medication and bloodwork are generally nonrefundable. Offer · Terms · Refund policy
What we actually verified
Before paying any program, ask who will prescribe in your state, which pharmacy will dispense the exact product, when refills are charged and sent, and how to get copies of your labs and medical records. Ask who handles a new symptom or an HIV-medication change between scheduled visits. A lab list and a monthly price cannot answer those questions for you.
Already on TRT with HIV? What should you check now?
Older studies found gaps in documented testing before TRT. If your own records are incomplete, don't stop on your own. Ask your prescriber and HIV team to review the diagnosis, hematocrit, blood pressure, prostate monitoring when appropriate, and possible interactions with your HIV regimen.
You wouldn't be alone. In records from seven U.S. HIV clinics during 1996–2011, 1,482 men started TRT. Only 24% had a low total-testosterone result documented beforehand; 33% had no recorded pre-treatment total-testosterone measurement. Missing records do not establish that no testing occurred elsewhere. The study's roughly 2.5-fold comparison used a separate U.S. insurance-claims estimate, not a matched group or a current prescribing rate. CNICS study
None of that means your treatment is wrong. It means it's worth a second look. Bring these questions:
- Was my low testosterone confirmed with repeat morning tests before I started?
- What were we hoping TRT would improve, and has it?
- When were my hematocrit and blood pressure last checked, and is PSA monitoring appropriate for me?
- Did my HIV regimen change since I started? If so, has anyone rechecked for interactions?
If levels normalize but symptoms don't improve, ask your prescriber to reassess the diagnosis, other causes, and whether treatment should continue. That decision belongs with your prescriber, not with a website. Never stop or change your dose on your own.
The Endocrine Society recommends checking testosterone about 3–6 months after starting and hematocrit at baseline, 3–6 months, and then annually. The timing of a testosterone blood sample depends on the product. Follow-up also reviews symptoms and side effects, with blood-pressure and prostate monitoring as appropriate; individual risks may require closer checks. Monitoring guidance · FDA blood-pressure warning
Can you get TRT online with HIV in 2026?
Yes, when clinically appropriate and applicable prescribing requirements are met. Testosterone is a Schedule III controlled substance and needs a valid prescription. A federal temporary rule allows qualifying DEA-registered clinicians to prescribe it by video without a prior in-person evaluation through December 31, 2026; federal and state requirements still apply. Federal rule
The prescription must serve a legitimate medical purpose in the usual course of professional practice. Online availability is not a promise that a clinician can or should prescribe for you. The DEA's permanent special-registration rule was still under White House review when checked on October 30, 2026. Pending rule record
Schedule III is the federal category for drugs with medical uses that are still tightly controlled. Testosterone was placed in Schedule III under the Anabolic Steroid Control Act of 1990, effective February 27, 1991. FDA hosted a testosterone expert panel in December 2025, but testosterone remains Schedule III as of October 2026. DEA scheduling · Effective date · FDA panel
What this means for you: if you start TRT online, keep copies of your lab results and prescriptions. If the rules change on January 1, 2027, your clinic may ask for an in-person visit. A prior qualifying in-person evaluation and other legal pathways can also support remote prescribing; the temporary extension is not the only pathway. Ask your clinic how it will keep your care connected if requirements change.
What should you bring to your next appointment?
Bring your full medicine list, every hormone lab report you have, a short symptom timeline, and your plans for children. Then leave with a clear answer to one question: who is responsible for your testosterone follow-up, and how will they talk to your HIV team?
That last part matters when more than one clinician is involved. One man in an online discussion about HIV and TRT put it simply: he'd have to get his doctors to talk to each other. This checklist is built to make that happen. Print it or screenshot it.
Your HIV + testosterone appointment checklist
Before the visit, write down:
- Every HIV medicine you take, including any booster (cobicistat or ritonavir)
- All other prescriptions, supplements, and any testosterone or hormone product
- Your hormone lab reports, with dates, time of day, units, and whether each test was before or during treatment
- When your symptoms started and what changed around that time
- Any weight change you didn't plan
- Whether you want biological children, now or later
Ask your clinician:
- If I have not started treatment, can we confirm the result with repeat early-morning fasting tests and a reliable free-testosterone assessment when needed?
- If I am already on TRT, when should my blood sample be taken for my exact product?
- Should we check LH and FSH to find the cause?
- Has a pharmacist checked my HIV regimen against testosterone?
- What's my hematocrit and blood-pressure starting point, and is PSA testing appropriate for me?
- Is the testosterone you'd prescribe FDA-approved or compounded, and which pharmacy will dispense it?
- What would count as TRT working for me, and when will we review it?
Before you leave, agree on:
TRT and HIV: common questions
HIV alone does not rule out TRT, and a low lab number alone does not establish that you need it. These answers cover the testing, medicine, and care questions to resolve with your clinicians.
Can you take testosterone if you're HIV positive?
Yes. Men with HIV may use testosterone when symptoms or signs and repeat early-morning fasting tests support the diagnosis and treatment fits their health needs. Their HIV medicines, blood count, blood pressure, and heart risk need to be reviewed too. HIV alone doesn't rule TRT out. Guidance
Does Biktarvy lower testosterone?
The Liverpool checker does not expect a clinically significant interaction between Biktarvy and prescribed testosterone, although the evidence is very low. That does not answer whether Biktarvy caused a person's low testosterone. The fix is proper testing, not switching your HIV medicine. Biktarvy interaction entry
Does testosterone interact with Genvoya, Symtuza, or Prezcobix?
These regimens contain cobicistat, a booster that may raise exposure to prescribed testosterone. That doesn't rule out TRT. It means your prescriber may monitor your levels and side effects more closely. Liverpool entry · Integrase chart
Will TRT affect my CD4 count or viral load?
A small, 12-week randomized trial in men with HIV and low testosterone found no statistically significant change in CD4 counts or viral load. That does not establish long-term safety with every HIV regimen. Keep up your usual HIV labs. Trial
Does everyone with HIV need a yearly testosterone test?
No. HIVMA/IDSA guidance doesn't recommend routine testosterone testing for all men with HIV. It recommends morning testing when there are symptoms or signs, such as low sex drive, erection problems, bone loss, or hot flashes and sweats. HIVMA/IDSA guidance
Does a testosterone number below 300 ng/dL mean I need TRT?
Not by itself. Diagnosis needs symptoms or signs plus repeat, accurate early-morning fasting tests, and the cause matters. With HIV, free testosterone and SHBG can change how a total number should be read. Diagnostic guidance
Is testosterone a treatment for HIV?
No. HIV treatment controls the virus. Testosterone may treat confirmed symptomatic hypogonadism. It never replaces your HIV medicine.
Can I use testosterone gel instead of injections?
Testosterone comes as injections, gels, and other forms. Which one fits is a decision for you and your prescriber. Gels can rub off onto partners or children through skin contact, so ask how to prevent that. Androderm patches were discontinued in the U.S.; a historical patch trial does not mean patches are available now. No single form is proven best for men with HIV. Formulation guidance · Patch discontinuation
I'm a transgender man with HIV. Does this guide apply?
Not fully. Gender-affirming testosterone uses different goals and monitoring. The interaction table may still be useful to discuss with your gender-affirming care team and HIV pharmacist.
Will my insurance or ADAP cover testosterone?
It depends on your plan and your state. Ask whether the exact product needs prior authorization. Ryan White ADAP drug lists are set state by state. Ask your case manager or insurer before you pay out of pocket. ADAP information
How we built this guide
This guide compares clinical guidance, original studies, drug-interaction records, and provider disclosures checked on October 30, 2026. The tables distinguish what a study found, what a provider states, and our editorial conclusions.
We started with the practical questions: Is my test right? Will it mess with my meds? Is it safe for my heart? Who handles this?
- Testing: HIVMA/IDSA 2024 Primary Care Guidance and the Endocrine Society 2018 guideline and July 2026 statement. We compared these against the dated UCSF Ward 86 recommendations and the MACS free-testosterone study. Fertility guidance comes from the inspected AUA/ASRM male-infertility guideline.
- Interactions: Six individual testosterone interaction entries checked directly in the University of Liverpool HIV Drug Interactions checker on October 30, 2026, plus its June 2026 charts for every additional combination or component listed.
- Safety and law: FDA and HHS labeling announcements, the DEA controlled-substance schedules, and the federal telehealth extension.
- Providers: Published pricing, lab-panel details, product disclosures, and terms, read and dated October 30, 2026, using our method, How We Review TRT Providers. We separate verified facts, company statements, customer-experience reports, and our own editorial conclusions. The cost model shows the known charges and the gaps that prevent an all-in quote. This page does not score providers.
The verification date records this review. Provider terms and federal telehealth rules can change; use the linked current source and confirm your own care plan before paying. See our editorial standards or send a correction.
Ready to explore general online TRT programs after talking with your HIV team? Use our free Find My TRT Path tool.
Sources
- HIVMA/IDSA. 2024 Primary Care Guidance Update for Providers Who Care for Persons with HIV.
- Bhasin S, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. 2018.
- Endocrine Society. Statement on Testosterone Replacement Therapy. July 16, 2026.
- Monroe AK, et al. Morning free and total testosterone in HIV-infected men: implications for the assessment of hypogonadism. 2014.
- Lachâtre M, et al. HIV and hypogonadism: a new challenge for young-aged and middle-aged men on effective antiretroviral therapy. 2017.
- De Vincentis S, Rochira V. Update on acquired hypogonadism in men living with HIV. 2023 review.
- Wunder DM, et al. Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy. 2007.
- UCSF Ward 86 / AIDS Education and Training Center. Testosterone Replacement Treatment for HIV-infected Men with Androgen Deficiency. Updated October 2018.
- University of Liverpool HIV Drug Interactions: BIC/FTC/TAF, DTG/3TC, DOR/3TC/TDF, DRV/c, EFV, and CAB/RPV LA with testosterone. Checked October 30, 2026.
- Liverpool June 2026 summary charts: integrase inhibitors, protease inhibitors, NNRTIs, and entry inhibitors; androgen-interaction guidance, December 2025.
- Burger D, et al. Concomitant use of anabolic androgen steroids and cabotegravir/rilpivirine leading to virological failure. 2024. Case details reviewed through Liverpool's attributed summary.
- Bhasin S, et al. 1998 testosterone patch trial; 2000 testosterone and resistance-exercise trial in men with HIV, weight loss, and low testosterone.
- Vorkas CK, Vaamonde CM, Glesby MJ. Testosterone therapy and polycythemia in HIV-infected patients. 2011.
- Lincoff AM, et al. Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE). 2023.
- Bhatia R, et al. Testosterone replacement therapy among HIV-infected men in the CFAR Network of Integrated Clinical Systems. 2015.
- Khandwala YS, et al. Variation in Practice Pattern of Male Hypogonadism. Published online 2017.
- AUA/ASRM. Diagnosis and treatment of infertility in men: guideline part II. 2021 publication.
- FDA testosterone labeling announcement, February 28, 2025; HHS requested labeling updates, June 18, 2026.
- Oxandrolone approval withdrawal, June 28, 2023, and October 7, 2026 correction.
- Current prescribing information: Serostim, clomiphene, and Pregnyl hCG; federal information on enclomiphene, January 2026.
- DEA/HHS fourth temporary telemedicine extension; pending special-registration rule record; DEA Schedule III information and 1991 effective-date record.
- FDA expert panel, December 10, 2025; FDA compounding information; ASHP testosterone-patch discontinuation bulletin; HRSA ADAP information.
- Hone Health: TRT pricing, Premium details, lab schedule, testosterone product disclosure, clinical policy, state availability, and cancellation policy. Read October 30, 2026.
- Male Excel: pricing, hormone test, service description, FAQ, terms, and refund policy. Read October 30, 2026.
- Taurus Meds: homepage, test page, offer page, terms, refund policy, and company-issued May 28, 2026 release. Read October 30, 2026.